Literature DB >> 31786156

Calciotropic and phosphotropic hormones in fetal and neonatal bone development.

Brittany A Ryan1, Christopher S Kovacs2.   

Abstract

There are remarkable differences in bone and mineral metabolism between the fetus and adult. The fetal mineral supply is from active transport across the placenta. Calcium, phosphorus, and magnesium circulate at higher levels in the fetus compared to the mother. These high concentrations enable the skeleton to accrete required minerals before birth. Known key regulators in the adult include parathyroid hormone (PTH), calcitriol, fibroblast growth factor-23, calcitonin, and the sex steroids. But during fetal life, PTH plays a lesser role while the others appear to be unimportant. Instead, PTH-related protein (PTHrP) plays a critical role. After birth, serum calcium falls and phosphorus rises, which trigger an increase in PTH and a subsequent rise in calcitriol. The intestines become the main source of mineral supply while the kidneys reabsorb filtered minerals. This striking developmental switch is triggered by loss of the placenta, onset of breathing, and the drop in serum calcium.
© 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcitriol; Calcium; Fetus; Fibroblast growth factor-23; Intestinal calcium absorption; Mineralization; Neonate; Parathyroid hormone; Parathyroid hormone-related protein; Phosphorus; Skeleton

Year:  2019        PMID: 31786156     DOI: 10.1016/j.siny.2019.101062

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  5 in total

Review 1.  Vitamin D: Before, during and after Pregnancy: Effect on Neonates and Children.

Authors:  José Luis Mansur; Beatriz Oliveri; Evangelina Giacoia; David Fusaro; Pablo René Costanzo
Journal:  Nutrients       Date:  2022-05-01       Impact factor: 6.706

Review 2.  Hormonal regulation of biomineralization.

Authors:  Andrew Arnold; Elaine Dennison; Christopher S Kovacs; Michael Mannstadt; René Rizzoli; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2021-03-16       Impact factor: 43.330

3.  Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.

Authors:  Samantha R Weaver; Earnest L Taylor; Elizabeth L Zars; Katherine M Arnold; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2021-02-08       Impact factor: 6.741

4.  European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.

Authors:  Jens Bollerslev; Lars Rejnmark; Alexandra Zahn; Ansgar Heck; N M Appelman-Dijkstra; Luis Cardoso; Fadil M Hannan; Filomena Cetani; Tanja Sikjær; Anna Maria Formenti; Sigridur Björnsdottir; Camilla Schalin-Jantti; Zhanna Belaya; Fraser Wilson Gibb; Bruno Lapauw; Karin Amrein; Corinna Wicke; Corinna Grasemann; Michael Krebs; Eeva M Ryhänen; Ozer Makay; Salvatore Minisola; Sebastien Gaujoux; Jean-Philippe Bertocchio; Zaki K Hassan-Smith; Agnès Linglart; Elizabeth M Winter; Martina Kollmann; Hans-Georg Zmierczak; Elena Tsourdi; Stefan Pilz; Heide Siggelkow; Neil J Gittoes; Claudio Marcocci; Peter Kamenicky
Journal:  Eur J Endocrinol       Date:  2022-01-13       Impact factor: 6.664

5.  Inorganic Phosphate in the Pathogenesis of Pregnancy-Related Complications.

Authors:  Ana Correia-Branco; Monica P Rincon; Leonardo M Pereira; Mary C Wallingford
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.